Support : You get advice on how to maintain your energy and overall health
Chronic Dosing Protocol: AOD9604 administered intraperitoneally at 250 g/kg/day hGH administered at 1 mg/kg/day Treatment duration: 1428 days depending on cohort Daily administration via intraperitoneal injection Acute Testing Protocol: Single AOD9604 dose: 2 mg/kg 3-AR agonist BRL37344: 250 g/kg (for comparison) Indirect calorimetry measurements performed Measured Outcomes: Body weight, food intake, white adipose tissue (WAT) and brown adipose tissue (BAT) weights, plasma glycerol levels (indicating lipolysis), and 3-AR mRNA expression in adipose tissue
Are you ready to get started
We source exclusively from a licensed Florida 503A pharmacy
For joint discomfort, adjustments to the dosage under clinical supervision usually resolve the issue
TB500, a synthetic version of thymosin beta-4, is involved primarily in promoting cell migration and reducing inflammation, which can speed up recovery from injuries
